Summary: A new review clarifies important differences between primate and rodent stress-hormone systems, offering insight into why many treatments for stress-related disorders have failed to translate from animals to humans. The authors report that corticotropin releasing factor (CRF) engages dopamine circuits in primates in broader and more complex ways, and that many primate dopamine neurons co-release multiple neurotransmitters.
These species-specific distinctions challenge the dominance of rodent models for studying human stress biology and underscore the need for higher animal models and individualized strategies in mental health research and treatment. The review also emphasizes how age, sex, and early-life experiences may shape individual vulnerability to psychiatric conditions.
Key Facts:
- CRF–Dopamine Complexity: Dopamine systems in primates are more diverse and multiplexed than those in rodents.
- Explaining Treatment Gaps: Rodent-based findings miss important anatomical and chemical differences, which helps explain limited clinical success.
- Toward Personalization: Future therapies should consider individual variation, sex differences, and developmental stress exposure.
Source: Genomic Press
In a comprehensive review published in Genomic Psychiatry, researchers at the University of Rochester Medical Center synthesize decades of evidence on stress-hormone systems in primates and outline implications for treating stress-related psychiatric disorders.
The review offers detailed analysis of how corticotropin releasing factor (CRF)—a central neuropeptide in the stress response—interacts with midbrain dopamine neurons, and it highlights major differences between primate and rodent brains that matter for translating preclinical findings to human treatments.
The Stress–Dopamine Connection: Greater Complexity in Primates
Stress responses are conserved across species, but the neural architecture that supports those responses varies. CRF modulates neural circuits during stress, and decades of rodent research have shaped our understanding of this system. Yet, clinical translation of rodent-based discoveries to effective human treatments has been disappointing.
“Our review highlights why higher animal models may be required to fully capture how stress affects the brain,” says Dr. Julie Fudge, the corresponding author. “There are subtle but important differences in CRF peptide and receptor distribution in primates compared with rodents, and those differences could underlie many of the translational setbacks we’ve seen.”
The team concentrated on the interface between CRF and the midbrain dopamine system—networks central to motivation, reward, and stress-related behaviors. Their synthesis shows that primates have expanded and more intricate dopamine neuron populations in regions implicated in psychiatric illness.
Anatomical Differences May Explain Clinical Failures
A key conclusion is that specific anatomical and molecular distinctions in the primate brain may explain why interventions that succeed in rodents often fail in human trials. The authors document a more diffuse distribution of CRF-expressing cells and distinct receptor expression patterns in primates that are not captured by rodent models.
These differences raise pressing questions: how do they change the dynamics of the stress response, and do they help explain the limited effectiveness of pharmacological approaches aimed at the CRF system in human patients?
“Recognizing species differences is not just theoretical—it is essential for developing next-generation treatments for depression, anxiety, and addiction,” Dr. Fudge notes. “Mapping how stress and dopamine systems interact in primates gives us a closer anatomic model for humans.”
Neurotransmitter Multiplexing: A Surprising Feature
The review presents preliminary evidence that dopamine neurons in primates are frequently multifunctional: many co-express and can release combinations of dopamine, glutamate, and GABA. This multiplexed signaling creates a more versatile and finely tuned chemical repertoire than has been appreciated from rodent studies.
While some multiple-transmitter dopamine neurons exist in rodents, the primate system appears to be more diverse and widespread. This complexity may reflect evolutionary adaptations to the social and environmental challenges primates face, enabling more nuanced stress responses.
“Neurons traditionally labeled as dopaminergic may actually perform a chemical symphony of signaling, allowing very specific responses to stress,” explains Dr. Fudge. “Such complexity helps explain why straightforward pharmacological strategies targeting single pathways often fall short.”
Future Directions: Toward Personalized Treatments
The authors recommend several priorities for future research: comprehensive mapping of CRF and dopamine interactions across species, and investigations into how age, sex, genetics, and early-life stress shape these systems. These factors are likely critical for developing personalized treatment strategies for stress-related disorders.
One pressing question is how early-life stress permanently alters CRF–dopamine circuitry in primates. Although developmental stress is linked to long-term mental health consequences, the exact neural mechanisms remain to be defined. Understanding receptor variants, hormonal influences, and individual trajectories could reveal why some people are resilient while others are vulnerable.
“Context, developmental timing, and individual differences matter enormously,” says Dr. Fudge. “The most promising therapeutic advances will come from treatments tailored to the unique patterns of stress circuitry in each patient rather than one-size-fits-all approaches.”
This review consolidates findings from laboratories around the world and lays out a clear roadmap for research that could change how we understand and treat stress-related mental illnesses.
About this stress research news
Author: Ma-Li Wong
Source: Genomic Press
Contact: Ma-Li Wong – Genomic Press
Image: The image is credited to Neuroscience News
Original Research: Open access. “Translating stress systems: corticotropin releasing factor, its receptors, and the dopamine system in nonhuman primate models” by Julie Fudge et al., Genomic Psychiatry. DOI: 10.61373/gp025i.0038
Abstract
Translating stress systems: corticotropin releasing factor, its receptors, and the dopamine system in nonhuman primate models
Stress is a universal biological challenge. Corticotropin releasing factor (CRF) is an evolutionarily conserved neuropeptide that modulates brain circuits and homeostatic responses during stress. In humans, dysregulation of monoamine systems that interact with CRF-rich circuits is implicated in many stress-related psychiatric disorders.
This review focuses on CRF interactions with the midbrain dopamine (DA) system in nonhuman primates. Although rodent studies have provided substantial mechanistic insight, the limited success of therapies derived from these models raises the question of whether higher animal models are necessary for translational progress.
The authors describe how subtle shifts in CRF peptide and receptor localization, along with the expansion and increased complexity of DA neuron populations in primates, may be key to understanding long-term stress effects on dopamine systems in humans. The laboratory’s work maps the neural architecture of the CRF–DA interface in nonhuman primates and highlights areas where additional primate-focused research can inform human health.